Contraindications for taking Rasagiline

Due to the risk of serotonin syndrome, rasagiline is contraindicated with pethidine, tramadol, methadone, propoxyphene, and MAO inhibitors (MAOIs), including other selective MAO-B inhibitors, and at least 14 days should elapse between discontinuation of rasagiline and initiation of treatment with these drugs. Rasagiline is contraindicated for use with dextromethorphan due to the risk of psychotic episodes or bizarre behavior.

Patients should be careful about the occurrence of adverse events such as hypertension, serotonin syndrome, somnolence and somnolence, liver function impairment, hypotension, dyskinesia, hallucinations/psychotic-like behavior, impulse control/obsessive-compulsive behavior, high fever and confusion after discontinuation of the drug while taking rasagiline to treat Parkinson's disease. If blood pressure continues to rise, medications may need to be adjusted. Patients should be advised to avoid foods containing high amounts of tyramine while taking recommended doses of rasagiline, as this may lead to substantial increases in blood pressure, including clinical syndromes known as hypertensive emergencies, crises, or emergencies.

The original drug of rasagiline has been launched in China and has entered the category of Class B medical insurance. The common name is rasagiline mesylate tablets, and the specifications areThe price of each box of 1mg*14 tablets may be around RMB 600. The price of the Turkish version of rasagiline's original drug, 1mg*30 tablets, per box sold overseas may be around RMB 310 (the price may fluctuate due to exchange rates). There are also generic drugs produced in other countries. The price of 1mg*100 tablets per box produced by Indian pharmaceutical factories may be around RMB 240 (the price may fluctuate due to the exchange rate). The pharmaceutical ingredients of generic drugs are basically the same as those of domestic and foreign original drugs. For specific prices and drug information, please consult Yaode Medical Consultant.